The role of the gut microbiome in systemic inflammatory disease

BMJ (Online)

Volumn 360, Issue , 2018, Pages

  Clemente, Jose C ^a   Manasson, Julia ^b   Scher, Jose U ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OIL; POLYUNSATURATED OIL; PREBIOTIC AGENT; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; DIETARY INTAKE; DISEASE COURSE; DYSBIOSIS; EVIDENCE BASED PRACTICE; FECAL MICROBIOTA TRANSPLANTATION; HEALTH CARE QUALITY; HUMAN; INFLAMMATORY BOWEL DISEASE; INTERVENTION STUDY; INTESTINE FLORA; MEDITERRANEAN DIET; METABOLITE; MICROBIAL COMMUNITY; MICROBIOME; MULTIPLE SCLEROSIS; NONHUMAN; OBESITY; PHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSORIASIS; RED MEAT; REVIEW; RHEUMATOID ARTHRITIS; SPONDYLARTHRITIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THERAPY EFFECT; WELLBEING; FEEDING BEHAVIOR; IMMUNOLOGY; INFLAMMATION; MICROBIOLOGY; MICROFLORA; MUCOSA; PATHOLOGY; PROCEDURES;

AUTOIMMUNE DISEASES; FECAL MICROBIOTA TRANSPLANTATION; FEEDING BEHAVIOR; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; MICROBIOTA; MUCOUS MEMBRANE; PREBIOTICS; PROBIOTICS;

EID: 85040458973     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.j5145     Document Type: Review

References (201)

1. Sender R, Fuchs S, Milo R. Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans. Cell 2016; 164: 337-40. doi: 10.1016/j.cell.2016.01.013 pmid: 26824647.
2. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008; 453: 620-5. doi: 10.1038/nature07008 pmid: 18509436.
3. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature 2007; 449: 804-10. doi: 10.1038/nature06244 pmid: 17943116.
4. Lederberg J. Infectious history. Science 2000; 288: 287-93. doi: 10.1126/.science.288.5464.287 pmid: 10777411.
5. David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505: 559-63. doi: 10.1038/nature12820 pmid: 24336217.
6. Abdollahi-Roodsaz S, Abramson SB, Scher JU. The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions. Nat Rev Rheumatol 2016; 12: 446-55. doi: 10.1038/.nrrheum.2016.68 pmid: 27256713.
7. Tamburini S, Shen N, Wu HC, Clemente JC. The microbiome in early life: implications for health outcomes. Nat Med 2016; 22: 713-22. doi: 10.1038/.nm.4142 pmid: 27387886.
8. Kernbauer E, Ding Y, Cadwell K. An enteric virus can replace the beneficial function of commensal bacteria. Nature 2014; 516: 94-8.pmid: 25409145.
9. Isaac S, Scher JU, Djukovic A, et al. Short-And long-Term effects of oral vancomycin on the human intestinal microbiota. J Antimicrob Chemother 2017; 72: 128-36. doi: 10.1093/jac/dkw383 pmid: 27707993.
10. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-8. doi: 10.1126/.science.1110591 pmid: 15831718.
11. Weisburg WG, Barns SM, Pelletier DA, Lane DJ. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 1991; 173: 697-703. doi: 10.1128/jb.173.2.697-703.1991 pmid: 1987160.
12. Hugenholtz P, Goebel BM, Pace NR. Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity. J Bacteriol 1998; 180: 4765-74.pmid: 9733676.
13. Huse SM, Dethlefsen L, Huber JA, Mark Welch D, Relman DA, Sogin ML. Exploring microbial diversity and taxonomy using SSU rRNA hypervariable tag sequencing. PLoS Genet 2008; 4: e1000255. doi: 10.1371/journal. pgen.1000255 pmid: 19023400.
14. Sogin ML, Morrison HG, Huber JA, et al. Microbial diversity in the deep sea and the underexplored rare biosphere. Proc Natl Acad Sci U S A 2006; 103: 12115-20. doi: 10.1073/pnas.0605127103 pmid: 16880384.
15. De Filippis F, Laiola M, Blaiotta G, Ercolini D. Different amplicon targets for sequencing-based studies of fungal diversity. Appl Environ Microbiol 2017; 83: e00905-17. doi: 10.1128/AEM.00905-17 pmid: 28625991.
16. Poretsky R, Rodriguez-R LM, Luo C, Tsementzi D, Konstantinidis KT. Strengths and limitations of 16S rRNA gene amplicon sequencing in revealing temporal microbial community dynamics. PLoS One 2014; 9: e93827. doi: 10.1371/journal.pone.0093827 pmid: 24714158.
17. Vineis JH, Ringus DL, Morrison HG, et al. Patient-Specific Bacteroides Genome Variants in Pouchitis. MBio 2016; 7: e01713-16. doi: 10.1128/.mBio.01713-16 pmid: 27935837.
18. Tringe SG, Rubin EM. Metagenomics: DNA sequencing of environmental samples. Nat Rev Genet 2005; 6: 805-14. doi: 10.1038/.nrg1709 pmid: 16304596.
19. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9: 313-23. doi: 10.1038/nri2515 pmid: 19343057.
20. Tyson GW, Chapman J, Hugenholtz P, et al. Community structure and metabolism through reconstruction of microbial genomes from the environment. Nature 2004; 428: 37-43. doi: 10.1038/.nature02340 pmid: 14961025.
21. Aguiar-Pulido V, Huang W, Suarez-Ulloa V, Cickovski T, Mathee K, Narasimhan G. Metagenomics, Metatranscriptomics, and Metabolomics Approaches for Microbiome Analysis. Evol Bioinform Online 2016; 12(Suppl 1): 5-16.pmid: 27199545.
22. Siggins A, Gunnigle E, Abram F. Exploring mixed microbial community functioning: recent advances in metaproteomics. FEMS Microbiol Ecol 2012; 80: 265-80. doi: 10.1111/j.1574-6941.2011.01284.x pmid: 22225547.
23. Vilanova C, Porcar M. Are multi-omics enough? Nat Microbiol 2016; 1: 16101. doi: 10.1038/nmicrobiol.2016.101 pmid: 27573112.
24. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368: 407-15. doi: 10.1056/NEJMoa1205037 pmid: 23323867.
25. Berer K, Krishnamoorthy G. Microbial view of central nervous system autoimmunity. FEBS Lett 2014; 588: 4207-13. doi: 10.1016/j.febslet.2014.04.007 pmid: 24746689.
26. Frick JS, Autenrieth IB. The gut microflora and its variety of roles in health and disease. Curr Top Microbiol Immunol 2013; 358: 273-89. doi: 10.1007/82-2012-217 pmid: 22476557.
27. Ahmed I, Roy BC, Khan SA, Septer S, Umar S. Microbiome, Metabolome and Inflammatory Bowel Disease. Microorganisms 2016; 4: E20. doi: 10.3390/.microorganisms4020020 pmid: 27681914.
28. Blander JM, Longman RS, Iliev ID, Sonnenberg GF, Artis D. Regulation of inflammation by microbiota interactions with the host. Nat Immunol 2017; 18: 851-60. doi: 10.1038/ni.3780 pmid: 28722709.
29. Gensollen T, Iyer SS, Kasper DL, Blumberg RS. How colonization by microbiota in early life shapes the immune system. Science 2016; 352: 539-44. doi: 10.1126/science.aad9378 pmid: 27126036.
30. Guo CJ, Chang FY, Wyche TP, et al. Discovery of Reactive Microbiota-Derived Metabolites that Inhibit Host Proteases. Cell 2017; 168: 517-526.e18. doi: 10.1016/j.cell.2016.12.021 pmid: 28111075.
31. Cohen LJ, Esterhazy D, Kim SH, et al. Commensal bacteria make GPCR ligands that mimic human signalling molecules. Nature 2017; 549: 48-53. doi: 10.1038/nature23874 pmid: 28854168.
32. Levin BJ, Huang YY, Peck SC, et al. A prominent glycyl radical enzyme in human gut microbiomes metabolizes trans-4-hydroxy-l-proline. Science 2017; 355: eaai8386. doi: 10.1126/science.aai8386 pmid: 28183913.
33. Dogan B, Suzuki H, Herlekar D, et al. Inflammation-Associated adherent-invasive Escherichia coli are enriched in pathways for use of propanediol and iron and M-cell translocation. Inflamm Bowel Dis 2014; 20: 1919-32. doi: 10.1097/MIB.0000000000000183 pmid: 25230163.
34. Atarashi K, Tanoue T, Ando M, et al. Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells. Cell 2015; 163: 367-80. doi: 10.1016/j.cell.2015.08.058 pmid: 26411289.
35. Hudcovic T, Stěpánková R, Cebra J, Tlaskalová-Hogenová H. The role of microflora in the development of intestinal inflammation: acute and chronic colitis induced by dextran sulfate in germ-free and conventionally reared immunocompetent and immunodeficient mice. Folia Microbiol (Praha) 2001; 46: 565-72. doi: 10.1007/BF02818004 pmid: 11898350.
36. Sellon RK, Tonkonogy S, Schultz M, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998; 66: 5224-31.pmid: 9784526.
37. Gkouskou KK, Deligianni C, Tsatsanis C, Eliopoulos AG. The gut microbiota in mouse models of inflammatory bowel disease. Front Cell Infect Microbiol 2014; 4: 28. doi: 10.3389/fcimb.2014.00028 pmid: 24616886.
38. Sokol H, Seksik P. The intestinal microbiota in inflammatory bowel diseases: time to connect with the host. Curr Opin Gastroenterol 2010; 26: 327-31. doi: 10.1097/MOG.0b013e328339536b pmid: 20445446.
39. Kolho KL, Korpela K, Jaakkola T, et al. Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation. Am J Gastroenterol 2015; 110: 921-30. doi: 10.1038/ajg.2015.149 pmid: 25986361.
40. Morgan XC, Tickle TL, Sokol H, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 2012; 13: R79. doi: 10.1186/gb-2012-13-9-r79 pmid: 23013615.
41. Machiels K, Joossens M, Sabino J, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 2014; 63: 1275-83. doi: 10.1136/gutjnl-2013-304833 pmid: 24021287.
42. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008; 105: 16731-6. doi: 10.1073/pnas.0804812105 pmid: 18936492.
43. Watanabe Y, Nagai F, Morotomi M. Characterization of Phascolarctobacterium succinatutens sp. nov., an asaccharolytic, succinate-utilizing bacterium isolated from human feces. Appl Environ Microbiol 2012; 78: 511-8. doi: 10.1128/AEM.06035-11 pmid: 22081579.
44. Forbes JD, Van Domselaar G, Bernstein CN. The Gut Microbiota in Immune-Mediated Inflammatory Diseases. Front Microbiol 2016; 7: 1081. doi: 10.3389/fmicb.2016.01081 pmid: 27462309.
45. Zechner EL. Inflammatory disease caused by intestinal pathobionts. Curr Opin Microbiol 2017; 35: 64-9. doi: 10.1016/j.mib.2017.01.011 pmid: 28189956.
46. Gevers D, Kugathasan S, Denson LA, et al. The treatment-naive microbiome in new-onset Crohn?s disease. Cell Host Microbe 2014; 15: 382-92. doi: 10.1016/j.chom.2014.02.005 pmid: 24629344.
47. Palm NW, de Zoete MR, Cullen TW, et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 2014; 158: 1000-10. doi: 10.1016/j.cell.2014.08.006 pmid: 25171403.
48. Viladomiu M, Kivolowitz C, Abdulhamid A, et al. IgA-coated E. coli enriched in Crohn?s disease spondyloarthritis promote TH17-dependent inflammation. Sci Transl Med 2017; 9: eaaf9655. doi: 10.1126/scitranslmed. aaf9655 pmid: 28179509.
49. Abdollahi-Roodsaz S, Joosten LA, Koenders MI, et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 2008; 118: 205-16. doi: 10.1172/JCI32639 pmid: 18060042.
50. Rogier R, Ederveen THA, Boekhorst J, et al. Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17-And TLR4-dependent arthritis. Microbiome 2017; 5: 63. doi: 10.1186/s40168-017-0278-2 pmid: 28645307.
51. Matsumoto I, Staub A, Benoist C, Mathis D. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 1999; 286: 1732-5. doi: 10.1126/science.286.5445.1732 pmid: 10576739.
52. Wu HJ, Ivanov II, Darce J, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010; 32: 815-27. doi: 10.1016/j.immuni.2010.06.001 pmid: 20620945.
53. Liu X, Zeng B, Zhang J, et al. Role of the Gut Microbiome in Modulating Arthritis Progression in Mice. Sci Rep 2016; 6: 30594. doi: 10.1038/.srep30594 pmid: 27481047.
54. Mizuno M, Noto D, Kaga N, Chiba A, Miyake S. The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models. PLoS One 2017; 12: e0173032. doi: 10.1371/journal. pone.0173032 pmid: 28235016.
55. Scher JU, Sczesnak A, Longman RS, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2013; 2: e01202. doi: 10.7554/eLife.01202 pmid: 24192039.
56. Maeda Y, Kurakawa T, Umemoto E, et al. Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine. Arthritis Rheumatol 2016; 68: 2646-61. doi: 10.1002/art.39783 pmid: 27333153.
57. Weinreich S, Eulderink F, Capkova J, et al. HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic mice. Hum Immunol 1995; 42: 103-15. doi: 10.1016/0198-8859(94)00034-N pmid: 7744613.
58. Reháková Z, Capková J, Stěpánková R, et al. Germ-free mice do not develop ankylosing enthesopathy, a spontaneous joint disease. Hum Immunol 2000; 61: 555-8. doi: 10.1016/S0198-8859(00)00122-1 pmid: 10825583.
59. Sinkorová Z, Capková J, Niederlová J, Stepánková R, Sinkora J. Commensal intestinal bacterial strains trigger ankylosing enthesopathy of the ankle in inbred B10.BR (H-2(k)) male mice. Hum Immunol 2008; 69: 845-50. doi: 10.1016/j.humimm.2008.08.296 pmid: 18840492.
60. Sakaguchi N, Takahashi T, Hata H, et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003; 426: 454-60. doi: 10.1038/nature02119 pmid: 14647385.
61. Yoshitomi H, Sakaguchi N, Kobayashi K, et al. A role for fungal beta-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J Exp Med 2005; 201: 949-60. doi: 10.1084/.jem.20041758 pmid: 15781585.
62. Taurog JD, Richardson JA, Croft JT, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994; 180: 2359-64. doi: 10.1084/.jem.180.6.2359 pmid: 7964509.
63. Lin P, Bach M, Asquith M, et al. HLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic rats. PLoS One 2014; 9: e105684. doi: 10.1371/journal.pone.0105684 pmid: 25140823.
64. Asquith MJ, Stauffer P, Davin S, Mitchell C, Lin P, Rosenbaum JT. Perturbed mucosal immunity and dysbiosis accompany clinical disease in a rat model of spondyloarthritis. Arthritis Rheumatol 2016; 68: 2151-62. doi: 10.1002/.art.39681 pmid: 26992013.
65. Asquith M, Davin S, Stauffer P, et al. Intestinal Metabolites Are Profoundly Altered in the Context of HLA-B27 Expression and Functionally Modulate Disease in a Rat Model of Spondyloarthritis. Arthritis Rheumatol 2017; 69: 1984-95. doi: 10.1002/art.40183 pmid: 28622455.
66. Costello ME, Ciccia F, Willner D, et al. Brief Report: Intestinal Dysbiosis in Ankylosing Spondylitis. Arthritis Rheumatol 2015; 67: 686-91. doi: 10.1002/art.38967 pmid: 25417597.
67. Stoll ML, Kumar R, Morrow CD, et al. Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis. Arthritis Res Ther 2014; 16: 486. doi: 10.1186/.s13075-014-0486-0 pmid: 25434931.
68. Stoll ML, Wilson L, Barnes S, et al. Multi-omics studies of gut microbiota in enthesitis-related arthritis identify diminished microbial diversity and altered tryptophan metabolism as potential factors in disease pathogenesis [abstract]. Arthritis Rheumatol 2015; 67(suppl 10
69. Scher JU, Ubeda C, Artacho A, et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol 2015; 67: 128-39. doi: 10.1002/art.38892 pmid: 25319745.
70. Brownlee WJ, Hardy TA, Fazekas F, Miller DH. Diagnosis of multiple sclerosis: progress and challenges. Lancet 2017; 389: 1336-46. doi: 10.1016/S0140-6736(16)30959-X pmid: 27889190.
71. Wekerle H, Berer K, Krishnamoorthy G. Remote control-Triggering of brain autoimmune disease in the gut. Curr Opin Immunol 2013; 25: 683-9. doi: 10.1016/j.coi.2013.09.009 pmid: 24161654.
72. Mirza A, Mao-Draayer Y. The gut microbiome and microbial translocation in multiple sclerosis. Clin Immunol 2017; 183: 213-24. doi: 10.1016/j.clim.2017.03.001 pmid: 28286112.
73. Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller DM. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993; 72: 551-60. doi: 10.1016/0092-8674(93)90074-Z pmid: 7679952.
74. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2011; 108(Suppl 1): 4615-22. doi: 10.1073/pnas.1000082107 pmid: 20660719.
75. Berer K, Mues M, Koutrolos M, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011; 479: 538-41. doi: 10.1038/nature10554 pmid: 22031325.
76. Yokote H, Miyake S, Croxford JL, Oki S, Mizusawa H, Yamamura T. NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. Am J Pathol 2008; 173: 1714-23. doi: 10.2353/.ajpath.2008.080622 pmid: 18974295.
77. Mudd AT, Berding K, Wang M, Donovan SM, Dilger RN. Serum cortisol mediates the relationship between fecal Ruminococcus and brain N-Acetylaspartate in the young pig. Gut Microbes 2017; July 13: 1-12. doi: 10.1080/19490976.2017.1353849 pmid: 28703640.
78. Haghikia A, Jörg S, Duscha A, et al. Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine. Immunity 2015; 43: 817-29. doi: 10.1016/j.immuni.2015.09.007 pmid: 26488817.
79. Farrokhi V, Nemati R, Nichols FC, et al. Bacterial lipodipeptide, Lipid 654, is a microbiome-Associated biomarker for multiple sclerosis. Clin Transl Immunology 2013; 2: e8. doi: 10.1038/cti.2013.11 pmid: 25505950.
80. Prinz M, Garbe F, Schmidt H, et al. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest 2006; 116: 456-64. doi: 10.1172/JCI26078 pmid: 16440059.
81. Anstadt EJ, Fujiwara M, Wasko N, Nichols F, Clark RB. TLR Tolerance as a Treatment for Central Nervous System Autoimmunity. J Immunol 2016; 197: 2110-8. doi: 10.4049/jimmunol.1600876 pmid: 27503211.
82. Ochoa-Repáraz J, Mielcarz DW, Ditrio LE, et al. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J Immunol 2010; 185: 4101-8. doi: 10.4049/jimmunol.1001443 pmid: 20817872.
83. Rothhammer V, Mascanfroni ID, Bunse L, et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med 2016; 22: 586-97. doi: 10.1038/nm.4106 pmid: 27158906.
84. Unni KK, Holley KE, McDuffie FC, Titus JL. Comparative study of NZB mice under germfree and conventional conditions. J Rheumatol 1975; 2: 36-44.pmid: 1185733.
85. Maldonado MA, Kakkanaiah V, MacDonald GC, et al. The role of environmental antigens in the spontaneous development of autoimmunity in MRL-lpr mice. J Immunol 1999; 162: 6322-30.pmid: 10352243.
86. Zhang H, Liao X, Sparks JB, Luo XM. Dynamics of gut microbiota in autoimmune lupus. Appl Environ Microbiol 2014; 80: 7551-60. doi: 10.1128/AEM.02676-14 pmid: 25261516.
87. Hevia A, Milani C, López P, et al. Intestinal dysbiosis associated with systemic lupus erythematosus. MBio 2014; 5: e01548-14. doi: 10.1128/.mBio.01548-14 pmid: 25271284.
88. He Z, Shao T, Li H, Xie Z, Wen C. Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus. Gut Pathog 2016; 8: 64. doi: 10.1186/s13099-016-0146-9 pmid: 27980687.
89. López P, de Paz B, Rodríguez-Carrio J, et al. Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients. Sci Rep 2016; 6: 24072. doi: 10.1038/.srep24072 pmid: 27044888.
90. Wu GD, Chen J, Hoffmann C, et al. Linking long-Term dietary patterns with gut microbial enterotypes. Science 2011; 334: 105-8. doi: 10.1126/.science.1208344 pmid: 21885731.
91. Muegge BD, Kuczynski J, Knights D, et al. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 2011; 332: 970-4. doi: 10.1126/.science.1198719 pmid: 21596990.
92. Korem T, Zeevi D, Zmora N, et al. Bread Affects Clinical Parameters and Induces Gut Microbiome-Associated Personal Glycemic Responses. Cell Metab 2017; 25: 1243-1253.e5. doi: 10.1016/j.cmet.2017.05.002 pmid: 28591632.
93. Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012; 486: 222-7.pmid: 22699611.
94. Clemente JC, Pehrsson EC, Blaser MJ, et al. The microbiome of uncontacted Amerindians. Sci Adv 2015; 1: e1500183. doi: 10.1126/.sciadv.1500183 pmid: 26229982.
95. Fallingborg J. Intraluminal pH of the human gastrointestinal tract. Dan Med Bull 1999; 46: 183-96.pmid: 10421978.
96. Zimmer J, Lange B, Frick JS, et al. A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur J Clin Nutr 2012; 66: 53-60. doi: 10.1038/ejcn.2011.141 pmid: 21811294.
97. Watson D, O?Connell Motherway M, Schoterman MH, van Neerven RJ, Nauta A, van Sinderen D. Selective carbohydrate utilization by lactobacilli and bifidobacteria. J Appl Microbiol 2013; 114: 1132-46. doi: 10.1111/jam.12105 pmid: 23240984.
98. Trompette A, Gollwitzer ES, Yadava K, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 2014; 20: 159-66. doi: 10.1038/nm.3444 pmid: 24390308.
99. Peng L, He Z, Chen W, Holzman IR, Lin J. Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr Res 2007; 61: 37-41. doi: 10.1203/01.pdr.0000250014.92242. f3 pmid: 17211138.
100. Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013; 504: 446-50. doi: 10.1038/nature12721 pmid: 24226770.
101. Jowett SL, Seal CJ, Pearce MS, et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut 2004; 53: 1479-84. doi: 10.1136/gut.2003.024828 pmid: 15361498.
102. Cohen SA, Gold BD, Oliva S, et al. Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2014; 59: 516-21. doi: 10.1097/.MPG.0000000000000449 pmid: 24897165.
103. Suskind DL, Wahbeh G, Gregory N, Vendettuoli H, Christie D. Nutritional therapy in pediatric Crohn disease: the specific carbohydrate diet. J Pediatr Gastroenterol Nutr 2014; 58: 87-91. doi: 10.1097/.MPG.0000000000000103 pmid: 24048168.
104. Day AS, Burgess L. Exclusive enteral nutrition and induction of remission of active Crohn?s disease in children. Expert Rev Clin Immunol 2013; 9: 375-83, quiz 384. doi: 10.1586/eci.13.12 pmid: 23557272.
105. Tjellström B, Högberg L, Stenhammar L, et al. Effect of exclusive enteral nutrition on gut microflora function in children with Crohn?s disease. Scand J Gastroenterol 2012; 47: 1454-9. doi: 10.3109/00365521.2012.703234 pmid: 23016828.
106. Wall CL, Day AS, Gearry RB. Use of exclusive enteral nutrition in adults with Crohn?s disease: a review. World J Gastroenterol 2013; 19: 7652-60. doi: 10.3748/wjg.v19.i43.7652 pmid: 24282355.
107. Di Giuseppe D, Crippa A, Orsini N, Wolk A. Fish consumption and risk of rheumatoid arthritis: a dose-response meta-Analysis. Arthritis Res Ther 2014; 16: 446. doi: 10.1186/s13075-014-0446-8 pmid: 25267142.
108. Di Giuseppe D, Alfredsson L, Bottai M, Askling J, Wolk A. Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study. BMJ 2012; 345: e4230. doi: 10.1136/bmj. e4230 pmid: 22782847.
109. Jin Z, Xiang C, Cai Q, Wei X, He J. Alcohol consumption as a preventive factor for developing rheumatoid arthritis: a dose-response meta-Analysis of prospective studies. Ann Rheum Dis 2014; 73: 1962-7. doi: 10.1136/.annrheumdis-2013-203323 pmid: 23897767.
110. Di Minno MN, Peluso R, Iervolino S, Russolillo A, Lupoli R, Scarpa R. CaRRDs Study Group. Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor a blockers. Ann Rheum Dis 2014; 73: 1157-62. doi: 10.1136/.annrheumdis-2012-202812 pmid: 23771989.
111. McKellar G, Morrison E, McEntegart A, et al. A pilot study of a Mediterranean-Type diet intervention in female patients with rheumatoid arthritis living in areas of social deprivation in Glasgow. Ann Rheum Dis 2007; 66: 1239-43. doi: 10.1136/ard.2006.065151 pmid: 17613557.
112. Sköldstam L, Hagfors L, Johansson G. An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis. Ann Rheum Dis 2003; 62: 208-14. doi: 10.1136/.ard.62.3.208 pmid: 12594104.
113. Hu Y, Costenbader KH, Gao X, Hu FB, Karlson EW, Lu B. Mediterranean diet and incidence of rheumatoid arthritis in women. Arthritis Care Res (Hoboken) 2015; 67: 597-606. doi: 10.1002/acr.22481 pmid: 25251857.
114. Lu B, Solomon DH, Costenbader KH, Karlson EW. Alcohol consumption and risk of incident rheumatoid arthritis in women: a prospective study. Arthritis Rheumatol 2014; 66: 1998-2005. doi: 10.1002/.art.38634 pmid: 24729427.
115. Hu Y, Sparks JA, Malspeis S, et al. Long-Term dietary quality and risk of developing rheumatoid arthritis in women. Ann Rheum Dis 2017; 76: 1357-64. doi: 10.1136/annrheumdis-2016-210431 pmid: 28137914.
116. Hagfors L, Nilsson I, Sköldstam L, Johansson G. Fat intake and composition of fatty acids in serum phospholipids in a randomized, controlled, Mediterranean dietary intervention study on patients with rheumatoid arthritis. Nutr Metab (Lond) 2005; 2: 26. doi: 10.1186/1743-7075-2-26 pmid: 16216119.
117. Hagfors L, Leanderson P, Sköldstam L, Andersson J, Johansson G. Antioxidant intake, plasma antioxidants and oxidative stress in a randomized, controlled, parallel, Mediterranean dietary intervention study on patients with rheumatoid arthritis. Nutr J 2003; 2: 5. doi: 10.1186/1475-2891-2-5 pmid: 12952549.
118. Wu GD, Compher C, Chen EZ, et al. Comparative metabolomics in vegans and omnivores reveal constraints on diet-dependent gut microbiota metabolite production. Gut 2016; 65: 63-72. doi: 10.1136/.gutjnl-2014-308209 pmid: 25431456.
119. De Filippis F, Pellegrini N, Vannini L, et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut 2016; 65: 1812-21. doi: 10.1136/.gutjnl-2015-309957 pmid: 26416813.
120. Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013; 504: 451-5. doi: 10.1038/nature12726 pmid: 24226773.
121. Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341: 569-73. doi: 10.1126/science.1241165 pmid: 23828891.
122. Rosell M, Wesley AM, Rydin K, Klareskog L, Alfredsson L. EIRA study group. Dietary fish and fish oil and the risk of rheumatoid arthritis. Epidemiology 2009; 20: 896-901. doi: 10.1097/.EDE.0b013e3181b5f0ce pmid: 19730266.
123. Linos A, Kaklamani VG, Kaklamani E, et al. Dietary factors in relation to rheumatoid arthritis: a role for olive oil and cooked vegetables? Am J Clin Nutr 1999; 70: 1077-82.pmid: 10584053.
124. Shapiro JA, Koepsell TD, Voigt LF, Dugowson CE, Kestin M, Nelson JL. Diet and rheumatoid arthritis in women: a possible protective effect of fish consumption. Epidemiology 1996; 7: 256-63. doi: 10.1097/00001648-199605000-00007 pmid: 8728438.
125. Fortin PR, Lew RA, Liang MH, et al. Validation of a meta-Analysis: the effects of fish oil in rheumatoid arthritis. J Clin Epidemiol 1995; 48: 1379-90. doi: 10.1016/0895-4356(95)00028-3 pmid: 7490601.
126. Proudman SM, James MJ, Spargo LD, et al. Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use. Ann Rheum Dis 2015; 74: 89-95. doi: 10.1136/.annrheumdis-2013-204145 pmid: 24081439.
127. Lee YH, Bae SC, Song GG. Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-Analysis. Arch Med Res 2012; 43: 356-62. doi: 10.1016/j.arcmed.2012.06.011 pmid: 22835600.
128. Norling LV, Perretti M. The role of omega-3 derived resolvins in arthritis. Curr Opin Pharmacol 2013; 13: 476-81. doi: 10.1016/j.coph.2013.02.003 pmid: 23434193.
129. Rosillo MA, Sánchez-Hidalgo M, Sánchez-Fidalgo S, Aparicio-Soto M, Villegas I, Alarcón-de-la-Lastra C. Dietary extra-virgin olive oil prevents inflammatory response and cartilage matrix degradation in murine collagen-induced arthritis. Eur J Nutr 2016; 55: 315-25. doi: 10.1007/.s00394-015-0850-0 pmid: 25665892.
130. Silva S, Sepodes B, Rocha J, et al. Protective effects of hydroxytyrosol-supplemented refined olive oil in animal models of acute inflammation and rheumatoid arthritis. J Nutr Biochem 2015; 26: 360-8. doi: 10.1016/j.jnutbio.2014.11.011 pmid: 25620693.
131. Caesar R, Tremaroli V, Kovatcheva-Datchary P, Cani PD, Bäckhed F. Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling. Cell Metab 2015; 22: 658-68. doi: 10.1016/j.cmet.2015.07.026 pmid: 26321659.
132. Pattison DJ, Silman AJ, Goodson NJ, et al. Vitamin C and the risk of developing inflammatory polyarthritis: prospective nested case-control study. Ann Rheum Dis 2004; 63: 843-7. doi: 10.1136/.ard.2003.016097 pmid: 15194581.
133. Pattison DJ, Symmons DP, Lunt M, et al. Dietary risk factors for the development of inflammatory polyarthritis: evidence for a role of high level of red meat consumption. Arthritis Rheum 2004; 50: 3804-12. doi: 10.1002/.art.20731 pmid: 15593211.
134. Benito-Garcia E, Feskanich D, Hu FB, Mandl LA, Karlson EW. Protein, iron, and meat consumption and risk for rheumatoid arthritis: a prospective cohort study. Arthritis Res Ther 2007; 9: R16. doi: 10.1186/.ar2123 pmid: 17288585.
135. Salgado E, Bes-Rastrollo M, de Irala J, Carmona L, Gómez-Reino JJ. High Sodium Intake Is Associated With Self-Reported Rheumatoid Arthritis: A Cross Sectional and Case Control Analysis Within the SUN Cohort. Medicine (Baltimore) 2015; 94: e924. doi: 10.1097/.MD.0000000000000924 pmid: 26376372.
136. Sundström B, Johansson I, Rantapää-Dahlqvist S. Interaction between dietary sodium and smoking increases the risk for rheumatoid arthritis: results from a nested case-control study. Rheumatology (Oxford) 2015; 54: 487-93. doi: 10.1093/rheumatology/keu330 pmid: 25209067.
137. Binger KJ, Gebhardt M, Heinig M, et al. High salt reduces the activation of IL-4-And IL-13-stimulated macrophages. J Clin Invest 2015; 125: 4223-38. doi: 10.1172/JCI80919 pmid: 26485286.
138. Jacobi A, Langenbruch A, Purwins S, Augustin M, Radtke MA. Prevalence of Obesity in Patients with Psoriasis: Results of the National Study PsoHealth3. Dermatology 2015; 231: 231-8. doi: 10.1159/000433528 pmid: 26202333.
139. Li W, Han J, Qureshi AA. Obesity and risk of incident psoriatic arthritis in US women. Ann Rheum Dis 2012; 71: 1267-72. doi: 10.1136/.annrheumdis-2011-201273 pmid: 22562978.
140. Love TJ, Zhu Y, Zhang Y, et al. Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis 2012; 71: 1273-7. doi: 10.1136/.annrheumdis-2012-201299 pmid: 22586165.
141. Engin B, Kutlubay Z, Yardimci G, et al. Evaluation of body composition parameters in patients with psoriasis. Int J Dermatol 2014; 53: 1468-73. doi: 10.1111/ijd.12171 pmid: 25267412.
142. Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005; 141: 1527-34. doi: 10.1001/.archderm.141.12.1527 pmid: 16365253.
143. McGowan JW, Pearce DJ, Chen J, Richmond D, Balkrishnan R, Feldman SR. The skinny on psoriasis and obesity. Arch Dermatol 2005; 141: 1601-2. doi: 10.1001/archderm.141.12.1601 pmid: 16365269.
144. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32: 982-6. doi: 10.1016/0190-9622(95)91336-X pmid: 7751469.
145. Edson-Heredia E, Sterling KL, Alatorre CI, et al. Heterogeneity of response to biologic treatment: perspective for psoriasis. J Invest Dermatol 2014; 134: 18-23. doi: 10.1038/jid.2013.326 pmid: 23921949.
146. Eder L, Thavaneswaran A, Chandran V, Cook RJ, Gladman DD. Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis. Ann Rheum Dis 2015; 74: 813-7. doi: 10.1136/.annrheumdis-2013-204448 pmid: 24431392.
147. Romero-Talamás H, Aminian A, Corcelles R, Fernandez AP, Schauer PR, Brethauer S. Psoriasis improvement after bariatric surgery. Surg Obes Relat Dis 2014; 10: 1155-9. doi: 10.1016/j.soard.2014.03.025 pmid: 25443045.
148. Iannone F, Lopalco G, Rigante D, Orlando I, Cantarini L, Lapadula G. Impact of obesity on the clinical outcome of rheumatologic patients in biotherapy. Autoimmun Rev 2016; 15: 447-50. doi: 10.1016/j.autrev.2016.01.010 pmid: 26808074.
149. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011; 29: 415-45. doi: 10.1146/annurev-immunol-031210-101322 pmid: 21219177.
150. Mraz M, Haluzik M. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol 2014; 222: R113-27. doi: 10.1530/.JOE-14-0283 pmid: 25006217.
151. Cañete JD, Mease P. The link between obesity and psoriatic arthritis. Ann Rheum Dis 2012; 71: 1265-6. doi: 10.1136/.annrheumdis-2012-201632 pmid: 22798633.
152. Millsop JW, Bhatia BK, Debbaneh M, Koo J, Liao W. Diet and psoriasis, part III: role of nutritional supplements. J Am Acad Dermatol 2014; 71: 561-9. doi: 10.1016/j.jaad.2014.03.016 pmid: 24780177.
153. Birkenfeld S, Dreiher J, Weitzman D, Cohen AD. Coeliac disease associated with psoriasis. Br J Dermatol 2009; 161: 1331-4. doi: 10.1111/j.1365-2133.2009.09398.x pmid: 19785615.
154. Ojetti V, Aguilar Sanchez J, Guerriero C, et al. High prevalence of celiac disease in psoriasis. Am J Gastroenterol 2003; 98: 2574-5. doi: 10.1016/.S0002-9270(03)01717-9 pmid: 14638373.
155. De Bastiani R, Gabrielli M, Lora L, et al. Association between coeliac disease and psoriasis: Italian primary care multicentre study. Dermatology 2015; 230: 156-60. doi: 10.1159/000369615 pmid: 25662711.
156. Bhatia BK, Millsop JW, Debbaneh M, Koo J, Linos E, Liao W. Diet and psoriasis, part II: celiac disease and role of a gluten-free diet. J Am Acad Dermatol 2014; 71: 350-8. doi: 10.1016/j.jaad.2014.03.017 pmid: 24780176.
157. Ungprasert P, Wijarnpreecha K, Kittanamongkolchai W. Psoriasis and Risk of Celiac Disease: A Systematic Review and Meta-Analysis. Indian J Dermatol 2017; 62: 41-6. doi: 10.4103/0019-5154.198031 pmid: 28216724.
158. Michaëlsson G, Gerdén B, Hagforsen E, et al. Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet. Br J Dermatol 2000; 142: 44-51. doi: 10.1046/j.1365-2133.2000.03240.x pmid: 10651693.
159. Bejaoui M, Sokol H, Marteau P. Targeting the Microbiome in Inflammatory Bowel Disease: Critical Evaluation of Current Concepts and Moving to New Horizons. Dig Dis 2015; 33(Suppl 1): 105-12. doi: 10.1159/000437104 pmid: 26366577.
160. Gupta P, Andrew H, Kirschner BS, Guandalini S. Is lactobacillus GG helpful in children with Crohn?s disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr 2000; 31: 453-7. doi: 10.1097/00005176-200010000-00024 pmid: 11045848.
161. Fujimori S, Tatsuguchi A, Gudis K, et al. High dose probiotic and prebiotic cotherapy for remission induction of active Crohn?s disease. J Gastroenterol Hepatol 2007; 22: 1199-204. doi: 10.1111/j.1440-1746.2006.04535.x pmid: 17688660.
162. Schultz M, Timmer A, Herfarth HH, Sartor RB, Vanderhoof JA, Rath HC. Lactobacillus GG in inducing and maintaining remission of Crohn?s disease. BMC Gastroenterol 2004; 4: 5. doi: 10.1186/1471-230X-4-5 pmid: 15113451.
163. Malchow HA. Crohn?s disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn?s disease? J Clin Gastroenterol 1997; 25: 653-8. doi: 10.1097/00004836-199712000-00021 pmid: 9451682.
164. Rolfe VE, Fortun PJ, Hawkey CJ, Bath-Hextall F. Probiotics for maintenance of remission in Crohn?s disease. Cochrane Database Syst Rev 2006; 4: CD004 826.pmid: 17054217.
165. Rahimi R, Nikfar S, Rahimi F, et al. A meta-Analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn?s disease. Dig Dis Sci 2008; 53: 2524-31. doi: 10.1007/s10620-007-0171-0 pmid: 18270836.
166. Sood A, Midha V, Makharia GK, et al. The probiotic preparation, VSL#3 induces remission in patients with mild-To-moderately active ulcerative colitis. Clin Gastroenterol Hepatol 2009; 7: 1202-9.e1. doi: 10.1016/j.cgh.2009.07.016 pmid: 19631292.
167. Kato K, Mizuno S, Umesaki Y, et al. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment Pharmacol Ther 2004; 20: 1133-41. doi: 10.1111/.j.1365-2036.2004.02268.x pmid: 15569116.
168. Mallon P, McKay D, Kirk S, Gardiner K. Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2007; 4: CD00 5573.pmid: 17943867.
169. Petersen AM, Mirsepasi H, Halkjær SI, Mortensen EM, Nordgaard-Lassen I, Krogfelt KA. Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial. J Crohns Colitis 2014; 8: 1498-505. doi: 10.1016/j.crohns.2014.06.001 pmid: 24972748.
170. Zigra PI, Maipa VE, Alamanos YP. Probiotics and remission of ulcerative colitis: a systematic review. Neth J Med 2007; 65: 411-8.pmid: 18079563.
171. Looijer-van Langen MA, Dieleman LA. Prebiotics in chronic intestinal inflammation. Inflamm Bowel Dis 2009; 15: 454-62. doi: 10.1002/.ibd.20737 pmid: 18831524.
172. Benjamin JL, Hedin CR, Koutsoumpas A, et al. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn?s disease. Gut 2011; 60: 923-9. doi: 10.1136/.gut.2010.232025 pmid: 21262918.
173. Hafer A, Krämer S, Duncker S, Krüger M, Manns MP, Bischoff SC. Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study. BMC Gastroenterol 2007; 7: 36. doi: 10.1186/1471-230X-7-36 pmid: 17784949.
174. Casellas F, Borruel N, Torrejón A, et al. Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin. Aliment Pharmacol Ther 2007; 25: 1061-7. doi: 10.1111/j.1365-2036.2007.03288.x pmid: 17439507.
175. Slavin J. Fiber and prebiotics: mechanisms and health benefits. Nutrients 2013; 5: 1417-35. doi: 10.3390/nu5041417 pmid: 23609775.
176. Holscher HD. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes 2017; 8: 172-84. doi: 10.1080/19490976.2017.1290756 pmid: 28165863.
177. van de Wiele T, Boon N, Possemiers S, Jacobs H, Verstraete W. Inulin-Type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects. J Appl Microbiol 2007; 102: 452-60. doi: 10.1111/.j.1365-2672.2006.03084.x pmid: 17241351.
178. Alipour B, Homayouni-Rad A, Vaghef-Mehrabany E, et al. Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial. Int J Rheum Dis 2014; 17: 519-27.pmid: 24673738.
179. Zamani B, Golkar HR, Farshbaf S, et al. Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Int J Rheum Dis 2016; 19: 869-79. doi: 10.1111/1756-185X.12888 pmid: 27135916.
180. Hatakka K, Martio J, Korpela M, et al. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis-A pilot study. Scand J Rheumatol 2003; 32: 211-5. doi: 10.1080/03009740310003695 pmid: 14626627.
181. Pineda Mde L, Thompson SF, Summers K, de Leon F, Pope J, Reid G. A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. Med Sci Monit 2011; 17: CR347-54.pmid: 21629190.
182. Jenks K, Stebbings S, Burton J, Schultz M, Herbison P, Highton J. Probiotic therapy for the treatment of spondyloarthritis: a randomized controlled trial. J Rheumatol 2010; 37: 2118-25. doi: 10.3899/.jrheum.100193 pmid: 20716665.
183. Stebbings SM, Taylor C, Tannock GW, Baird MA, Highton J. The immune response to autologous bacteroides in ankylosing spondylitis is characterized by reduced interleukin 10 production. J Rheumatol 2009; 36: 797-800. doi: 10.3899/jrheum.080964 pmid: 19228651.
184. Groeger D, O?Mahony L, Murphy EF, et al. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes 2013; 4: 325-39. doi: 10.4161/gmic.25487 pmid: 23842110.
185. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368: 407-15. doi: 10.1056/NEJMoa1205037 pmid: 23323867.
186. Youngster I, Russell GH, Pindar C, Ziv-Baran T, Sauk J, Hohmann EL. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 2014; 312: 1772-8. doi: 10.1001/.jama.2014.13875 pmid: 25322359.
187. Kelly CR, Khoruts A, Staley C, et al. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial. Ann Intern Med 2016; 165: 609-16. doi: 10.7326/M16-0271 pmid: 27547925.
188. Weingarden AR, Hamilton MJ, Sadowsky MJ, Khoruts A. Resolution of severe Clostridium difficile infection following sequential fecal microbiota transplantation. J Clin Gastroenterol 2013; 47: 735-7. doi: 10.1097/.MCG.0b013e31829004ae pmid: 23632358.
189. Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012; 143: 913-6.e7. doi: 10.1053/j.gastro.2012.06.031 pmid: 22728514.
190. Borody TJ, Warren EF, Leis S, Surace R, Ashman O. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 2003; 37: 42-7. doi: 10.1097/00004836-200307000-00012 pmid: 12811208.
191. Kump PK, Gröchenig HP, Lackner S, et al. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm Bowel Dis 2013; 19: 2155-65. doi: 10.1097/.MIB.0b013e31829ea325 pmid: 23899544.
192. Rossen NG, Fuentes S, van der Spek MJ, et al. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis. Gastroenterology 2015; 149: 110-118.e4. doi: 10.1053/j.gastro.2015.03.045 pmid: 25836986.
193. Moayyedi P, Surette MG, Kim PT, et al. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology 2015; 149: 102-109.e6. doi: 10.1053/j.gastro.2015.04.001 pmid: 25857665.
194. Jacob V, Crawford C, Cohen-Mekelburg S, et al. Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis. Inflamm Bowel Dis 2017; 23: 903-11. doi: 10.1097/.MIB.0000000000001132 pmid: 28445246.
195. Grinspan AM, Kelly CR. Fecal Microbiota Transplantation for Ulcerative Colitis: Not Just Yet. Gastroenterology 2015; 149: 15-8. doi: 10.1053/j.gastro.2015.05.030 pmid: 26021232.
196. Paramsothy S, Kamm MA, Kaakoush NO, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 2017; 389: 1218-28. doi: 10.1016/.S0140-6736(17)30182-4 pmid: 28214091.
197. Ratner M. Seres?s pioneering microbiome drug fails mid-stage trial. Nat Biotechnol 2016; 34: 1004-5. doi: 10.1038/nbt1016-1004b pmid: 27727226.
198. Garber K. Drugging the gut microbiome. Nat Biotechnol 2015; 33: 228-31. doi: 10.1038/nbt.3161 pmid: 25748907.
199. Atarashi K, Tanoue T, Oshima K, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013; 500: 232-6. doi: 10.1038/nature12331 pmid: 23842501.
200. Olle B. Medicines from microbiota. Nat Biotechnol 2013; 31: 309-15. doi: 10.1038/nbt.2548 pmid: 23563425.
201. Abdollahi-Roodsaz S, Abramson SB, Scher JU. The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions. Nat Rev Rheumatol 2016; 12: 446-55. doi: 10.1038/.nrrheum.2016.68 pmid: 27256713.